机译:Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real‐life experience
Azienda Ospedaliero‐Universitaria di Bologna;
autologous stem‐cell transplantation; checkpoint inhibitors; Hodgkin lymphoma; real‐life; refractory; relapse;